Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2023

Stockholders' Equity [Abstract]

Schedule of Grant Date Fair Value for Stock Options is Estimated Using a Black-Scholes Option Valuation Model Using the Weighted-Average Assumptions

Grant date fair value for stock options is estimated using a Black-Scholes option valuation model using the weighted-average assumptions in the table below:

	Years ended December 31,
	2023			2022
Expected volatility		63.89	%		57.68	%
Dividend yield		0	%		0	%
Risk-free interest rate		4.28	%		3.34	%
Expected term in years		5.85			5.85

Schedule of Share Option and Restricted Stock Unit Activity Under Its Plans

A summary of the Company’s share option and restricted stock unit activity under its plans is as follows:

	Options							RSUs
	Number of Options			Weighted- Average Exercise Price per Share		Weighted- Average Remaining Contractual Term (In Years)		Number of RSUs			Weighted Average Grant Date Fair Value per Share
Balance as of December 31, 2021		72,744		$	53.18		7.12		—
Granted		17,145		$	22.98				131,858		$	79.29
Balance as of December 31, 2022		89,889		$	47.42		8.10		131,858		$	79.29
Granted		15,050		$	12.91				7,500		$	2.91
Released		—			—				(61,200	)	$	82.04
Canceled		(2,850	)	$	39.87				(1,242	)	$	88.60
Balance as of December 31, 2023		102,089		$	42.54		7.41		76,916		$	69.50
Exercisable at December 31, 2023		70,634		$	48.66		6.86

Schedule of Stock-Based Compensation Expense Recognized

The following table sets forth stock-based compensation expense recognized for the years ended December 31, 2023 and 2022:

	Years ended December 31,
	2023		2022
Research and development	$	1,504	$	995
Sales and marketing		217		117
General, and administrative		2,424		1,785
Total stock-based compensation expense	$	4,145	$	2,897